We are live on
!
Find out more
CDR
Clayton Dubilier & Rice Portfolio holdings
AUM
$895M
1-Year Est. Return
792.56%
This Fund
S&P 500
This Quarter
Est. Return
+8.71%
1 Year Est. Return
+792.56%
3 Year Est. Return
+175.84%
5 Year Est. Return
+204.57%
10 Year Est. Return
+288.13%
AUM
$4.56B
AUM Growth
-$554M
(-11%)
Cap. Flow
-$603M
Cap. Flow
% of AUM
-13.22%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$1.68B |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$223M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 61.34% |
| 2 | Healthcare | 38.66% |
Similar funds
SSA
JBA
FCM
TIS
SGDR
FC
WIM
BWP
Clayton Dubilier & Rice's Q3 2014 Portfolio in Review
As of Q3 2014, Clayton Dubilier & Rice held 4 positions worth $4.56B, down 11% from $5.12B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Clayton Dubilier & Rice withdrew a net $603M in Q3 2014, reducing 2 holdings. Its largest reduction was Envision Healthcare Holdings Inc, cutting an estimated $1.68B.
By sector, the portfolio is most concentrated in Industrials at 61% of assets, up from 31% a quarter earlier, followed by Healthcare.
Against the trend, Clayton Dubilier & Rice opened a new position in Terminix Global Holdings, Inc. worth $1.46B.
- Clayton Dubilier & Rice's largest Q3 2014 buy was Terminix Global Holdings, Inc.: 90,187,152 shares worth $1.46B.
- Clayton Dubilier & Rice's biggest Q3 2014 reduction was Envision Healthcare Holdings Inc, cutting an estimated $1.68B.
- Clayton Dubilier & Rice's ten largest holdings make up 100% of its $4.56B portfolio in Q3 2014.
- Clayton Dubilier & Rice opened 1 new position and closed 0 in Q3 2014.
- Clayton Dubilier & Rice's portfolio value fell 11% quarter-over-quarter to $4.56B.
Based on Clayton Dubilier & Rice's 13F filing for Q3 2014, filed 13 Nov 2014.